Cargando…
Complement activation in vivo in cancer patients receiving C. parvum immunotherapy.
Serum complement levels were assayed in 26 patients with disseminated cancer, who received immunotherapy with infusion of C. parvum. Complement activation, indicated by the consumption of C3 or C4 or both, was found in 46% of the patients. Serum samples showed direct correlation between decreased C3...
Autores principales: | Biran, H., Moake, J. L., Reed, R. C., Gutterman, J. U., Hersh, E. M., Freireich, E. J., Mavligit, G. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1976
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025195/ https://www.ncbi.nlm.nih.gov/pubmed/999783 |
Ejemplares similares
-
Effect of C. parvum and active specific immunotherapy on intracerebral transplants of a murine fibrosarcoma.
por: Woodruff, M. F., et al.
Publicado: (1977) -
Assembly and Activation of Alternative Complement Components on Endothelial Cell-Anchored Ultra-Large Von Willebrand Factor Links Complement and Hemostasis-Thrombosis
por: Turner, Nancy A., et al.
Publicado: (2013) -
Abrogation of the anti-metastatic activity of C. parvum by antilymphocyte serum.
por: Sadler, T. E., et al.
Publicado: (1976) -
Mechanisms of C. Parvum-induced coagulopathy in mice.
por: Mitcheson, H. D., et al.
Publicado: (1980) -
Immune-complex disease in mice and humans given C. parvum.
por: Mitcheson, H. D., et al.
Publicado: (1980)